JPWO2023170302A5 - - Google Patents

Info

Publication number
JPWO2023170302A5
JPWO2023170302A5 JP2024553833A JP2024553833A JPWO2023170302A5 JP WO2023170302 A5 JPWO2023170302 A5 JP WO2023170302A5 JP 2024553833 A JP2024553833 A JP 2024553833A JP 2024553833 A JP2024553833 A JP 2024553833A JP WO2023170302 A5 JPWO2023170302 A5 JP WO2023170302A5
Authority
JP
Japan
Prior art keywords
amino acid
jun
sequence
variant
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024553833A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025510591A5 (https=
JP2025510591A (ja
Publication date
Priority claimed from GBGB2203399.7A external-priority patent/GB202203399D0/en
Application filed filed Critical
Publication of JP2025510591A publication Critical patent/JP2025510591A/ja
Publication of JP2025510591A5 publication Critical patent/JP2025510591A5/ja
Publication of JPWO2023170302A5 publication Critical patent/JPWO2023170302A5/ja
Pending legal-status Critical Current

Links

JP2024553833A 2022-03-11 2023-03-10 ｃ－Ｊｕｎアンタゴニストペプチド Pending JP2025510591A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2203399.7 2022-03-11
GBGB2203399.7A GB202203399D0 (en) 2022-03-11 2022-03-11 c-jun antagonist peptides
PCT/EP2023/056243 WO2023170302A1 (en) 2022-03-11 2023-03-10 C-jun antagonist peptides

Publications (3)

Publication Number Publication Date
JP2025510591A JP2025510591A (ja) 2025-04-15
JP2025510591A5 JP2025510591A5 (https=) 2026-03-13
JPWO2023170302A5 true JPWO2023170302A5 (https=) 2026-03-13

Family

ID=81254979

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024553833A Pending JP2025510591A (ja) 2022-03-11 2023-03-10 ｃ－Ｊｕｎアンタゴニストペプチド

Country Status (7)

Country Link
US (1) US20250188151A1 (https=)
EP (1) EP4490176A1 (https=)
JP (1) JP2025510591A (https=)
CN (1) CN118984835A (https=)
CA (1) CA3245706A1 (https=)
GB (1) GB202203399D0 (https=)
WO (1) WO2023170302A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118252913B (zh) * 2024-02-07 2024-09-17 中国医学科学院阜外医院 多肽偶联物及其在射血分数保留的心衰中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516891A (en) 1992-06-16 1996-05-14 Kinerton, Ltd. Liquid phase synthesis of peptides and peptide derivatives
US20100029552A1 (en) * 2004-08-20 2010-02-04 Phylogica Limited Peptide inhibitors of c-jun dimerization and uses thereof
GB201820863D0 (en) 2018-12-20 2019-02-06 Univ Bath Screening assay
GB202009710D0 (en) 2020-06-25 2020-08-12 Univ Bath Cross-linking methods

Similar Documents

Publication Publication Date Title
JP5211109B2 (ja) 膜転位剤および製薬学的有効成分の複合物
JP4129298B2 (ja) 胃腸管（ｇｉｔ）輸送受容体に結合するランダムペプチド、及び関連した方法
CN101553243B (zh) 组织损伤修复中的基质细胞衍生因子1的蛋白酶抗性突变体
FI3642340T3 (fi) Muunneltu l-asparaginaasi
JP2013513377A5 (https=)
JP2005506340A5 (https=)
JP2008521426A5 (https=)
US10046024B2 (en) Cyclic-GluR6 analogs, methods of treatment and use
JPH03503539A (ja) 抗マラリヤワクチンとして有用な多重抗原ペプチドの樹木状ポリマー
JP2025120320A (ja) Ｖｉｐｒ２アンタゴニストペプチド
JP6857875B2 (ja) 新規な細胞膜透過性ペプチド
JP2007506713A (ja) 例えば、抗血管新生活性を有するペプチドおよび治療におけるその適用
JPH02500517A (ja) ペプチド化合物
CN106163569B (zh) 活化的神经降压素分子及其用途
JP7239987B2 (ja) 薬物送達のための抗体融合タンパク質
JPWO2023170302A5 (https=)
JPH08511542A (ja) コイル状−コイルステムループ鋳型
JPWO2021229076A5 (https=)
CN119630790A (zh) 新型lrp1结合肽
KR102274876B1 (ko) 신규한 세포 투과성 펩타이드 및 이의 용도
JPH05271291A (ja) 機能性ポリペプチド
JP2005508875A5 (https=)
JPWO2020024915A5 (https=)
EP2909235B1 (en) Polypeptides specifically binding to il-23
JPWO2023110983A5 (https=)